Trademark: RESTASIS MULTIDOSE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
RESTASIS MULTIDOSE
Click here to search for trademarks similar to RESTASIS MULTIDOSE
Proof of use for RESTASIS MULTIDOSE
We do not have any records of a proof of use for RESTASIS MULTIDOSE at this moment.
Possible trademark infringements of RESTASIS MULTIDOSE
Basic Information about RESTASIS MULTIDOSE
- Serial Number
- 87216956
- Filing Date
- 26 Oct 2016
- Registration Number
- 5243078
- Registration Date
- 11 Jul 2017
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of RESTASIS MULTIDOSE on the blockchain with WikiTrademarks.io.
- First use of RESTASIS MULTIDOSE anywhere
- RESTASIS MULTIDOSE was first used on 24 Feb 2017 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns RESTASIS MULTIDOSE?
Correspondent
- Cheryl A. Withycombe
- AbbVie Inc.
- Mail code: AND-250C
- 18655 Teller Avenue
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io